# US 2010/0167319 A1 · Diagnose of Mycobacterial Infections by Determination of IFN-Gamma

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167319 A1
- Document ID: US20100167319A1
- Status: Published application
- Kind: A1
- Application number: 12/377,660
- Filed: 2007-08-14
- Published: 2010-07-01
- Earliest claimed: 2006-08-15
- Assignees: The Pirbright Institute
- Inventors: Jayne Hope; Paul Sopp; Chris Howard
- Web page: https://patentgrep.com/patent/US20100167319A1

## CPC

- G01N 33/5695: {Mycobacteria}
- G01N 33/6863: {Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a method for diagnosing a mycobacterial infection in a subject, involving the following steps: (i) collection of a sample from the subject; (ii) incubation of the sample from (i) with an antigen preparation for 12 hours or less; and (iii) analysis of γ-IFN in the sample from (ii). The invention also provides a diagnostic kit for use in such a method.

## Claims

### Claim 1

A method for diagnosing a mycobacterial infection in a subject, which comprises the following steps:
(i) collection of a sample from the subject;
(ii) incubation of the sample from (i) with an antigen preparation for 10 hours or less; and
(iii) analysis of γ-IFN in the sample from (ii).

### Claim 2 (depends on 1)

A method according to claim 1, wherein the mycobacterial infection is infection with M. tuberculosis.

### Claim 3 (depends on 1)

A method according to claim 1, wherein the mycobacterial infection is infection with M. paratuberculosis.

### Claim 4

A method according to any preceding claim, wherein in step (ii), the incubation time is between 2 and 8 hours.

### Claim 5 (depends on 4)

A method according to claim 4, wherein in step (ii), the incubation time is between 3 and 6 hours.

### Claim 6 (depends on 5)

A method according to claim 5, wherein in step (ii), the incubation time is between 4 and 5 hours.

### Claim 7

A method according to any proceeding claim, wherein step (iii), γ-IFN in the sample is analysed by a rapid test system.

### Claim 8 (depends on 7)

A method according to claim 7, wherein γ-IFN in the sample is analysed using a dipstick or lateral flow assay (LFA).

### Claim 9 (depends on 1, 2, 3, 4, 5, 6)

A method according to any of claims 1 to 6, wherein in step (in), γ-IFN in the sample is analysed using an enzyme-linked immunosorbent assay (ELISA).

### Claim 10 (depends on 1, 2, 3, 4, 5, 6)

A method according to any of claims 1 to 6, wherein in step (iii) γ-IFN in the sample is analysed using Fluorescence Polarisation (FP)

### Claim 11

A method according to any preceding claim, wherein in step (iii), γ-IFN in the sample is quantitated or compared using an electronic readout system.

### Claim 12 (depends on 11)

A method according to claim 11, wherein the electronic readout system is a reflectometer.

### Claim 13 (depends on 11)

A method according to claim 11, wherein the electronic readout system is or comprises an ultramicroelectrode interdigitated array.

### Claim 14

A method according to any preceding claim, wherein the subject is selected from the following group: cow, badger, human, horse, sheep, pig or goat.

### Claim 15

A method according to any preceding claim which is used to distinguish between anti-TB vaccinated and TB-infected subjects.

### Claim 16

A one-day kit for diagnosis of mycobacterial infection in a subject which comprises the following:
(i) an incubation tube containing an antigen-preparation; and
(ii) a test for analysis of the amount of γ-IFN in a sample post-incubation.

### Claim 17 (depends on 16)

A kit according to claim 16, wherein the test is a solid-phase test

### Claim 18 (depends on 17)

A kit according to claim 17, wherein the solid-phase test is a lateral flow assay (LFA) or a dipstick.

### Claim 19 (depends on 16, 17, 18)

A kit according to any of claims 16 to 18, wherein the incubation tube is adapted to receive the sample directly after collection.

### Claim 20 (depends on 16, 17, 18, 19)

A kit according to any of claims 16 to 19 which, in addition to analysis of γ-IFN following incubation with antigen, is adapted to measure another parameter.

### Claim 21 (depends on 20)

A kit according to claim 20, wherein the solid phase test is a multiplex LFA.
